Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Rubrik faces a pivotal Q1 print, with traders watching for signs of margin expansion and cash flow improvement after ...
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
A new migration wave shows Florida's longtime senior influx slowing. Thousands of retirees are moving north, altering...
SpaceX hit the market with a bang, as spacex stock climbed first in its debut week. This analysis looks at what histo...
A longer drawdown horizon and stubborn inflation are reshaping retirement strategy. Today’s retirees need more stock ...
A quiet powerhouse sits at the center of financial markets. S&P Global turns data, ratings, and benchmarks into relia...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...
Warren Buffett recently shifted how he gives and invests, reportedly donating billion in Berkshire Hathaway stock whi...
Walmart and Costco together account for about 28.7% of XLP’s assets, tightening concentration and raising questions a...
Classrooms face a sharp debate as AI tools spread. Educators warn that students can’t reason, while families recalibr...
A new survey of large U.S. companies finds finance leaders divided they'd on how to use tariff refunds, with only a m...